Study guide

15.2 DLCO & Exercise Test Reliability

NBRC Registered Pulmonary Function Technologist RPFT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Content Outline Domains & Study Plan

2 Spirometry Instrumentation

2.1 Spirometer Types, Setup & Maintenance 2.2 Spirometer Calibration & Linearity 2.3 Spirometer Troubleshooting

3 Blood Gas & Gas Analyzers

3.1 Blood Gas Analyzer Setup, Maintain, Calibrate 3.2 Gas Analyzers & Water/Gas Absorbers 3.3 ABG & Gas Analyzer Troubleshooting and QC

4 Body Box, Exercise & Monitoring Equipment

4.1 Body Plethysmograph Setup & Calibration 4.2 Exercise, Field Walking & ECG Equipment 4.3 Pressure Devices, Valves & Gas Delivery Systems

5 Ancillary Equipment & Infection Control

5.1 Body Habitus, Sampling & Aerosol Equipment 5.2 Monitors & Emergency Management Equipment 5.3 Infection Control Materials & Methods

6 Quality Control Systems

6.1 Mechanical QC Devices 6.2 Biological Controls & Proficiency Testing 6.3 Laboratory Quality Management & SOPs

7 Patient Preparation & Safety

7.1 Body Habitus Measurements & Estimates 7.2 Patient Safety, Precautions & Adverse Events

8 Spirometry Procedures

8.1 Selecting Spirometry Protocols & Equipment 8.2 Performing Standard & Position-Variant Spirometry 8.3 Evaluating Spirometry Acceptability & Repeatability 8.4 Bronchodilator Response Studies

9 Static Lung Volumes

9.1 Gas Dilution Lung Volume Methods 9.2 Body Plethysmography Lung Volumes 9.3 Evaluating Lung Volume Validity

10 Diffusing Capacity (DLCO)

10.1 DLCO Protocol & Equipment Selection 10.2 Performing the DLCO Maneuver 10.3 Evaluating DLCO Validity

11 Blood Gas Sampling & Analysis Procedures

11.1 Arterial & Capillary Blood Sample Collection 11.2 Performing Blood Gas Analysis 11.3 CO-oximetry / Hemoximetry Procedures

12 Airway Responsiveness, Resistance & Muscle Strength

12.1 Bronchial Provocation Studies 12.2 Airways Resistance & Conductance by Plethysmography 12.3 Respiratory Muscle Strength (MIP/MEP/CPF)

13 Exercise, Oxygen, Home Testing & Education

13.1 Field Walking Tests (6MWT, Shuttle) 13.2 Monitored Exercise Testing 13.3 Oxygen Assessment & Titration 13.4 Home Testing Instruction & Patient Education

14 Calculations & Reference Ranges

14.1 Spirometry Calculations & Reference Equations 14.2 Lung Volume & DLCO Calculations/Corrections 14.3 Blood Gas & CO-oximetry Derived Calculations 14.4 Exercise, Oximetry & Special Test Calculations

15 Evaluating Result Reliability

15.1 Spirometry & Lung Volume Reliability 15.2 DLCO & Exercise Test Reliability 15.3 ABG, Monitoring & QC Reliability

16 Clinical Implications & Reporting

16.1 Pattern Recognition: Obstruction, Restriction, Mixed, Severity 16.2 Clinical Implications: DLCO, ABG, Airway Response, Exercise & Lab Context

15.2 DLCO & Exercise Test Reliability

Key Takeaways Explain This Topic AI

DLCO reliability (III.B.5) hinges on inspired volume vs VC, breath-hold quality/timing, alveolar sample integrity, and recognition of COHb and related confounders.

A mathematically complete DLCO printout is unreliable if VI/VC is inadequate, BHT is wrong, or the sample is contaminated by dead-space or leak.

Exercise and field-walk reliability (III.B.6–7) requires protocol adherence, valid SpO2 (motion/perfusion), measured course distance, and appropriate practice walks.

Home testing (III.B.8) expands access but weakens unsupervised effort, environment, and device-quality controls—report and interpret with those limits explicit.

When DLCO or walk metrics are technically compromised, retest or qualify the report; do not treat artifact as diffusion defect or true exertional desaturation.

Last updated: August 2026

DLCO Reliability Is More Than a Green Checkmark

After Domain II acceptability for single-breath DLCO, III.B.5 asks whether the reported diffusing capacity is reliable enough for clinical use. CO uptake numbers are sensitive to inspired volume , breath-hold timing , gas sample purity , and blood CO/hemoglobin state . An RPFT who only glances at “DLCO % predicted” without those checks will mislabel technical failure as interstitial disease—or miss a real diffusion defect hidden under a short breath-hold.

  • Core DLCO Reliability Checks
  • Inspired volume relative to VC (VI/VC)

The patient must inspire a large fraction of vital capacity so alveolar volume and CO distribution represent the lung being tested.

  • VI/VC situation Reliability implication Typical action
  • VI clearly adequate vs concurrent VC Supports usable VA/DLCO Proceed if other criteria met

VI substantially below expected VC fraction Under-inspiration; DLCO/VA may be biased Recoach full inspiration; repeat

  • VC itself unreliable (incomplete spirometry) VI/VC ratio loses meaning Fix spirometry effort first
  • Leak during inspiration Inspired volume false Reject trial

Exam stems often pair a “low DLCO” with a tracing showing small inspired volume and weak effort—reliability answer is retest , not pulmonary fibrosis narrative.

Breath-hold time (BHT)

BHT must match the method’s timing definition (ATS/ERS-aligned start/end rules used by the instrument and SOP). Too short or too long, or an unsteady hold with Valsalva/Müller straining, undermines the single-breath model.

Unreliable BHT patterns:

  • Patient exhales early or inhales during “hold”
  • Glottic leak (CO/tracer continuum unstable)
  • Extreme pressures (strain) altering pulmonary blood volume
  • Software BHT outside acceptable window with no override justification
  • Alveolar sample quality

DLCO depends on analyzing alveolar gas , not dead-space–heavy early gas or room-air contamination.

Sample problem Effect Reliability response

Inadequate washout volume before sample Dead-space contamination → erroneous FA_CO/FA_tracer Reject; adjust discard/sample volumes per standards/SOP

  • Leak at mouthpiece during hold/exhalation Tracer/CO dilution errors Reject; reseat; repeat
  • Analyzer lag/mis-timing Wrong portion of exhalate Service/method check; do not average bad samples
  • Water/CO2 handling faults Biased analyzer readings Equipment QC path
  • COHb and related confounders

Carboxyhemoglobin from smoking or CO exposure occupies Hb binding sites and alters measured DLCO. Reliability judgment includes:

  • Documented smoking/vaping timing relative to test
  • Measured COHb (when available) and appropriate correction/reporting practice per lab standards

Anemia/polycythemia (Hb) affecting CO uptake—often corrected in reporting but still part of reliability/context

Recent supplemental O2 affecting comparison to room-air reference conditions

A low DLCO in a patient who smoked immediately before testing is not automatically ILD until COHb and maneuver quality are addressed. Conversely, normal-looking DLCO with high COHb may still be clinically misleading without correction notes.

Replicate agreement

Within-session DLCO trials should cluster . Large scatter after several attempts means low reliability even if one value looks “pretty.” Prefer standards-aligned averaging rules only among acceptable trials.

Exercise & Field-Walk Reliability (III.B.6–7)

Exercise and walking tests produce distance, symptoms, SpO2, heart rate, and sometimes BP/ECG . Reliability fails when the protocol or sensors fail—even if the patient “tried hard.”

Protocol adherence

  • Element Unreliable if… Why it matters
  • Timing (e.g., 6 minutes) Clock wrong; early stop undocumented Distance not comparable
  • Instructions / encouragement Inconsistent scripting Effort and distance shift
  • Supplemental O2 policy FiO2 changes mid-walk without plan SpO2/distance uninterpretable vs prior
  • Workload steps (CPET/treadmill) Stage skips, speed errors Metabolic comparisons invalid
  • Stop criteria Continue through unsafe symptoms or stop without reason codes Safety + data integrity
  • Oximeter reliability (motion & perfusion)

Pulse oximeters during walking are vulnerable to motion artifact , poor perfusion, ambient light, and probe placement.

Suspect SpO2 unreliability when:

  • Pulse rate from oximeter disagrees with ECG/palpated rate
  • SpO2 jumps erratically without physiologic pattern
  • Cold fingers, nail coatings, or probe repeatedly reseated mid-test
  • Patient clenches probe hand on walker/treadmill rail

Reliable practice: optimize probe site before start, confirm pulse agreement, treat wild SpO2 swings as artifact until proven , and document signal quality. Do not report a dramatic “desaturation” from a single motion-glitch nadir without waveform/pulse corroboration.

Practice walks and learning effect

A first 6MWT often underestimates true distance because of unfamiliarity. Standards commonly support a practice consideration or standardized repeat strategy. Reliability of “best distance” depends on whether the lab’s protocol for practice/repeat was followed and documented. Comparing today’s first-ever walk to last year’s third walk without noting learning effect is a reliability trap.

Course measurement errors

Distance is only as good as the course .

  • Error Effect
  • Unmeasured or guessed corridor length Systematic bias in meters/feet
  • Turns counted inconsistently Random error, poor serial comparison
  • Different course than prior visit False improvement/decline
  • Obstacles / busy hallway stops Nonphysiologic distance limits

Exam answer when distance “falls 80 m” but the lab moved from a 30 m to an unmarked short hallway: question reliability of the comparison before declaring clinical worsening.

Home Testing Reliability Limitations (III.B.8)

Home spirometry and related remote testing improve access and serial sampling frequency, but reliability is constrained :

  • Unsupervised effort — no real-time flow-volume coaching by an RPFT
  • Device quality & calibration state — consumer/home sensors may lack full lab QC
  • Environment — posture, nose clip use, distractions, illness day effects
  • Maneuver selection — software may auto-pick peaks the patient cannot validate
  • Context gaps — medication timing, smoking, recent exercise often incomplete

Reliability posture for the exam: Home data can trend and screen , but discordant or decision-critical values usually need laboratory confirmation . Reports should state unsupervised limitations rather than treat home FEV1 as identical in authority to a standards-aligned lab session.

Integrated Exam Scenarios

DLCO scenario: VI is 55% of measured VC, BHT short with leak flags, patient smoked 20 minutes prior, DLCO 45% predicted. Reliability: Do not lock in severe diffusion defect; correct process (inspiration, hold, COHb/timing) and retest.

Walk scenario: 6MWT SpO2 falls to 82% for two seconds while oximeter HR is 40 bpm and ECG shows 118 bpm; distance protocol correct. Reliability: SpO2 nadir is motion/perfusion artifact until a stable probe agrees with pulse; do not treat 82% as proven desaturation.

Home scenario: Home FEV1 drops 400 mL overnight; lab spirometry next day is repeatable and near baseline with good peaks. Reliability: Weight the supervised session higher; investigate home effort/device factors.

Workflow Checklist (III.B.5–8)

DLCO: VI/VC → BHT → sample/leak → replicate agreement → COHb/Hb/O2 context.

Exercise/walk: protocol clock & coaching → course length → practice-walk policy → SpO2 pulse agreement → symptom scores documented.

Home: label limitations; confirm critical decisions in lab when stakes are high.

If any pillar fails: retest or qualify —never silently convert technical failure into a disease label.

Mastering these reliability gates is what Domain III.B scores: not recalling the DLCO formula alone, but knowing when the formula’s inputs were never trustworthy.